Decreasing Rates of Fracture-Related Hospitalization With Primary Biliary Cholangitis: Insights From the Nationwide Inpatient Sample

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Jun 20

PMID 35719819

Authors

Zaid Ansari

Ishani Shah

Abhishek Bhurwal

Harsh Mehta

Surabhi Uppal

Indu Srinivasan

Savio Reddymasu

Keng-Yu Chuang

Affiliations

Soon will be listed here.

Abstract

Introduction Primary biliary cholangitis (PBC) is associated with an increased risk of developing fractures. Current guidelines recommend measures that can help prevent the development of fractures in these patients. The purpose of this study was to trend the rates of hospitalizations related to fractures and their burden on healthcare. Methods We performed a retrospective, cohort study of adults hospitalized in the United States with PBC between 2010 and 2014. Patients were identified using the Nationwide Inpatient Sample (NIS). Temporal analysis of PBC patients with a co-diagnosis of hip, vertebral, or wrist fractures (the study group) was performed with regards to the total number of inpatient admissions, inpatient mortality, length of stay, and total charges associated with hospitalization. Descriptive analyses were performed using the -test for continuous data and the test for categorical data. Results During the five-year study period, there were 308,753 hospitalizations for PBC. There has been a downward trend (p=0.02) in fracture-related admissions among patients with PBC during this study period. Length of stay was higher in the PBC-fracture group (10.85 days vs 7.36 days; p<0.001). Total hospitalization charges were higher among the PBC-fracture patients when compared to the control group ($98,444 vs $72,964; p=0.004). Conclusion There has been a gradual reduction in the rate of fracture-related hospitalizations in patients with PBC. However, patients with PBC who have fractures have increased the utilization of health care resources as compared to their cohort admitted for reasons other than for a fracture.

References

Siris E, Miller P, Barrett-Connor E, Faulkner K, Wehren L, Abbott T . Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001; 286(22):2815-22. DOI: 10.1001/jama.286.22.2815. View

Ruiz-Gaspa S, Guanabens N, Enjuanes A, Peris P, Martinez-Ferrer A, Martinez de Osaba M . Lithocholic acid downregulates vitamin D effects in human osteoblasts. Eur J Clin Invest. 2010; 40(1):25-34. DOI: 10.1111/j.1365-2362.2009.02230.x. View

Leibson C, Tosteson A, Gabriel S, Ransom J, Melton L . Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002; 50(10):1644-50. DOI: 10.1046/j.1532-5415.2002.50455.x. View

Wariaghli G, Allali F, El Maghraoui A, Hajjaj-Hassouni N . Osteoporosis in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2010; 22(12):1397-401. DOI: 10.1097/MEG.0b013e3283405939. View

Guanabens N, Pares A, Ros I, Caballeria L, Pons F, Vidal S . Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol. 2005; 42(4):573-7. DOI: 10.1016/j.jhep.2004.11.035. View

Solaymani-Dodaran M, Card T, Aithal G, West J . Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology. 2006; 131(6):1752-7. DOI: 10.1053/j.gastro.2006.09.012. View

Herlong H, Recker R, Maddrey W . Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology. 1982; 83(1 Pt 1):103-8. View

Bernstein C, Leslie W, LeBoff M . AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003; 124(3):795-841. DOI: 10.1053/gast.2003.50106. View

Gonzalez-Calvin J, Munoz-Torres M, Mundi J . Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology. 1998; 28(3):695-9. DOI: 10.1002/hep.510280315. View

10.

Wolford M, Palso K, Bercovitz A . Hospitalization for total hip replacement among inpatients aged 45 and over: United States, 2000-2010. NCHS Data Brief. 2015; (186):1-8. View

11.

Danford C, Trivedi H, Papamichael K, Tapper E, Bonder A . Osteoporosis in primary biliary cholangitis. World J Gastroenterol. 2018; 24(31):3513-3520. PMC: 6102495. DOI: 10.3748/wjg.v24.i31.3513. View

12.

Carey E, Ali A, Lindor K . Primary biliary cirrhosis. Lancet. 2015; 386(10003):1565-75. DOI: 10.1016/S0140-6736(15)00154-3. View

13.

Kawelke N, Bentmann A, Hackl N, Hager H, Feick P, Geursen A . Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. J Bone Miner Res. 2008; 23(8):1278-86. DOI: 10.1359/jbmr.080313. View

14.

Polychronopoulou E, Lygoura V, Gatselis N, Dalekos G . Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis. BMJ Case Rep. 2017; 2017. PMC: 5747690. DOI: 10.1136/bcr-2017-220824. View

15.

Marschall H, Henriksson I, Lindberg S, Soderdahl F, Thuresson M, Wahlin S . Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Sci Rep. 2019; 9(1):11525. PMC: 6687809. DOI: 10.1038/s41598-019-47890-2. View

16.

Boonstra K, Beuers U, Ponsioen C . Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012; 56(5):1181-1188. DOI: 10.1016/j.jhep.2011.10.025. View

17.

Jha S, Wang Z, Laucis N, Bhattacharyya T . Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996-2012: An Ecological Analysis. J Bone Miner Res. 2015; 30(12):2179-87. PMC: 11131130. DOI: 10.1002/jbmr.2565. View

18.

Ananthakrishnan A, McGinley E, Binion D, Saeian K . Fracture-associated hospitalizations in patients with inflammatory bowel disease. Dig Dis Sci. 2010; 56(1):176-82. DOI: 10.1007/s10620-010-1433-9. View

19.

Guanabens N, Cerda D, Monegal A, Pons F, Caballeria L, Peris P . Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology. 2010; 138(7):2348-56. DOI: 10.1053/j.gastro.2010.02.016. View

20.

Lindor K, Jorgensen R, Tiegs R, Khosla S, Dickson E . Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. J Hepatol. 2000; 33(6):878-82. DOI: 10.1016/s0168-8278(00)80118-x. View